scorpion
- 13 Aug 2003 13:54
Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.
Fred1new
- 20 Apr 2005 09:39
- 1930 of 2372
BPRG is held by a number of large institutions. Bought at varying prices as long term holds.
As above I believe there hasn't been any large institutional sells recently and a few buys reasonable sized institutional buys to-day (19th/4/05).
Interesting it has about 14.4Mil in cash and NAV of about 14.4p.
I have bought worse, but glad I bought at about 27p Wed.
superrod
- 20 Apr 2005 10:28
- 1931 of 2372
i bought at 35.96 and im out for now at 41p......experience tells me there is invariably a fall back in these situations.
Dil
- 20 Apr 2005 11:26
- 1932 of 2372
hyleo - what happened to your "bargain" shares you were buying at 73p ?
bhunt1910
- 20 Apr 2005 12:28
- 1933 of 2372
I have monitored BPRG for a while - but dont hold any shares at the moment - (have done). Glad to see that they are bouncing back for those of you still holding. I still think that BPRG has some great products and a lot of potential- but dont know how to market them.
Good Luck all
Bazag
hlyeo98
- 21 Apr 2005 21:37
- 1934 of 2372
Up again today...recovering
Dil
- 21 Apr 2005 21:45
- 1935 of 2372
yeah be back to your bargain price of 73p anytime soon.
FWIW I think they are heading to 22p but what do I know
hlyeo98
- 22 Apr 2005 07:56
- 1936 of 2372
We will see in the long term who eat the heart out
Dil
- 22 Apr 2005 09:44
- 1937 of 2372
How long is long term ?
They've already lost over 70% of their value since I said they were crap last Feb and have now started heading down further again.
Dil
- 22 Apr 2005 19:29
- 1938 of 2372
hlyeo98 - 10 Nov'04 - 12:58 - 1257 of 1936
BOUGHT MORE TODAY AT 90P...IN THE LONG TERM THIS IS A SURE WINNER!!!
Let me know if you ever decide to go short hlyeo as thats the day I'll go out and buy a shedload.
aimtrader
- 24 Apr 2005 00:48
- 1939 of 2372
aimtrader - 14 Apr'05 - 21:45 - 1920 of 1937 edit
i think there will be further bad news, bit risky buying now i reckon...
i'm waiting for now...maybe a better entry point later
Well i seem to have called that one right!!!
aldwickk
- 24 Apr 2005 07:15
- 1940 of 2372
Dil,
How much did you loose going short on that share with no deal, what was it's name ? Oh, yes SEO.
Dil
- 24 Apr 2005 18:19
- 1941 of 2372
errr scuse me dipstick ... when did I ever say I shorted SEO ?
Dil
- 25 Apr 2005 20:00
- 1942 of 2372
Your silence speaks volumes , next time try thinking before putting your foot in your gob.
Sherif
- 25 Apr 2005 20:34
- 1943 of 2372
.
Fred1new
- 26 Apr 2005 00:23
- 1944 of 2372
Charmant Dil.
Fred1new
- 27 Apr 2005 11:50
- 1945 of 2372
Well Dill.
If I am reading the following correctly, there seems to be some institutional buying. (4.950,000 Shares)( It doesn't show price. I checked that Sharescope did not list Fidelity International as share holders prior to to-day. But I wish sometimes the bulletins would be a little more understandable.
I guess there is still some life in this "dog" yet.
BioProgress PLC
27 April 2005
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Bioprogress plc
2. Name of shareholder having a major interest
Fidelity International Limited
3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above
or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18.
As above
4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them
172,688 Brown Brothers Harriman Lux
4,777,312 Mellon Bank N.A.
5. Number of shares/amount of stock acquired
Not disclosed
6. Percentage of issued class
Not disclosed
7. Number of shares/amount of stock disposed
Not disclosed
8. Percentage of issued class
Not disclosed
9. Class of security
Ordinary shares of 1p each
10. Date of transaction
Not disclosed
11. Date company informed
25 April 2005
12. Total holding following this notification
4.950,000
13. Total percentage holding of issued class following this notification
4.2%
14. Any additional information
15. Name of contact and telephone number for queries
Elizabeth Edwards, 01354 655674
16. Name and signature of authorised company official responsible for making this notification.
Elizabeth Edwards, Company Secretary
Date of notification: 27 April 2005
This information is provided by RNS
The company news service from the London Stock Exchange
Dil
- 27 Apr 2005 13:24
- 1946 of 2372
Fred , ignore who or what is buying and whether the 1,000,000 is a buy or sell etc and concentrate on the price action.
That imo is the best indicator and I still don't think we have seen the bottom.
Bones
- 29 Apr 2005 14:35
- 1947 of 2372
Not before time, Graham Hind kicked out without a thank you in sight!
http://moneyam.uk-wire.com/cgi-bin/articles/200504291405017340L.html
Fred1new
- 29 Apr 2005 14:38
- 1948 of 2372
Dil Partially agree, but like to see volume and price up before I buy or sometimes opposite when I sell. Also prefer more than two birds in the bush.
I think that BPRG are trying to sort themselves out, but still would like to know what the real problems are. I am glad they have about 14Million is cash (I think and hope that this is so.) For now I am holding a few more than I wish I had and accept it is a Punt. (My favourite Kick.) Below just announced:
BioProgress PLC
29 April 2005
Press Release 29 April 2005
BioProgress plc
('BioProgress' or 'the Company')
Director Change
BioProgress plc (AIM: BPRG; NASDAQ: BPRG), announces that Graham Hind has today
resigned as Chief Executive Officer and Director of BioProgress.
The Company has appointed Richard Trevillion, currently a Non-Executive
Director, to act as interim Chief Executive Officer.
Richard Trevillion joined the Board in February 2005. He is the founder and CEO
of Amity Partners Limited, a principal healthcare and technology finance
business which has been responsible for numerous transactions since it was
formed in late 2002. A qualified solicitor, Mr Trevillion began his career with
law firms Lovell White Durrant and Simmons & Simmons, before moving to corporate
finance where his senior experience includes being co-Director at Arthur
Andersen responsible for their healthcare corporate finance team. Mr Trevillion
then became Head of Healthcare within the technology corporate finance group at
Close Brothers Corporate Finance in 2000.
The strategic and financial review, which the Board announced on 13 April 2005,
is continuing.
Dil
- 29 Apr 2005 14:53
- 1949 of 2372
Good luck Fred , think they may uncover some more crap before the "strategic review" is completed.
Ideal time to blame everything on the old management and bung a load of write offs into the accounts and start with a clean slate.